1. Home
  2. TROO vs ZURA Comparison

TROO vs ZURA Comparison

Compare TROO & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TROOPS Inc.

TROO

TROOPS Inc.

HOLD

Current Price

$2.28

Market Cap

480.1M

Sector

Technology

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$6.02

Market Cap

521.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROO
ZURA
Founded
2005
2022
Country
Hong Kong
United States
Employees
N/A
30
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
480.1M
521.8M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
TROO
ZURA
Price
$2.28
$6.02
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$11.78
AVG Volume (30 Days)
153.7K
502.2K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.99
52 Week High
$5.28
$7.25

Technical Indicators

Market Signals
Indicator
TROO
ZURA
Relative Strength Index (RSI) 38.37 48.93
Support Level $0.74 $5.49
Resistance Level $2.74 $6.99
Average True Range (ATR) 0.29 0.48
MACD -0.02 -0.01
Stochastic Oscillator 46.84 57.97

Price Performance

Historical Comparison
TROO
ZURA

About TROO TROOPS Inc.

TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: